Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

LVTX Stock Annual Income Statement. Download in Excel

LAVA Therapeutics N.V.

Sector: Manufacturing   

Industry: Pharmaceutical Preparation Manufacturing

1.31
 
USD
  
-0.03
  
(-2.24%)
Previous close: 1.34  Open: 1.33  Bid: 1.31  Ask: 1.4
52 week range    
0.85   
   2.45
Mkt Cap: 36 M  Avg Vol (90 Days): 46,586
Last updated: Friday 13th June 2025

Stock Rankings

48
MarketXLS Rank
54
Technical
42
Quality
How are these ranks calculated?
Financials

LVTX Income Statement

Annual
Invalid dateDec-21Dec-22Dec-23Dec-24
Basic EPS from continuing operations-1.57-0.94
Basic EPS total-2.3-1.23-1.57-0.94
Basic weighted shares outstanding20 M26 M27 M27 M
Cost of sales-54 M3 M
Depreciation-227000.0-277000.0500000.0
DepreciationAndAmortization-227000.0-277000.0500000.0
Diluted EPS total-2.28-1.23-1.57-0.94
Diluted normalized net income/share-1.57-0.94
Diluted weighted shares outstanding23 M31 M27 M27 M
Earnings from equity interest-6 M
EarningsFromEquityInterestNetOfTax-6 M
GainOnSaleOfPPE-6 M
GeneralAndAdministrativeExpense12 M14 M3 M13 M
Gross operating profit5 M19 M3 M12 M
Income before tax-45 M-32 M-42 M-24 M
Income taxes157000.0249000.0279000.0630000.0
InsuranceAndClaims3 M
Interest income3 M4 M
InterestExpenseNonOperating-625000.0232000.0500000.0
InterestExpenseOperating625000.0-257000.0
Net income from total operations-52 M-39 M-42 M-25 M
NetIncomeCommonStockholders-52 M-39 M-42 M-25 M
NetIncomeContinuousOperations-52 M-39 M-42 M-25 M
NetNonOperatingInterestIncomeExpense625000.0-7 M3 M4 M
Operating income-44 M-35 M-43 M-30 M
Operating income before depreciation (EBITDA)-45 M-31 M-24 M
OperatingExpense49 M54 M47 M42 M
Other income net6 M
OtherCostofRevenue3 M
OtherGandA12 M14 M3 M13 M
OtherOperatingExpenses574000.0
RentAndLandingFees12 M14 M
Research & development expense37 M40 M25 M28 M
ResearchExpense37 M40 M25 M28 M
SalariesAndWages-4 M18 M3 M
Selling Gen & administrative expense12 M14 M3 M13 M
Total Income available for interest expense (EBIT)-45 M-32 M-24 M
Total common shares outstanding26 M26 M26 M
Total net income-52 M-39 M-42 M-25 M
Total ordinary shares26 M26 M26 M26 M
Total revenues5 M19 M7 M12 M
TotalExpenses49 M50 M42 M
TotalRevenue5 M19 M7 M12 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement "your own" investment strategies in Excel with thousands of MarketXLS functions and templates.
MarketXLS provides all the tools I need for in-depth stock analysis. It's user-friendly and constantly improving. A must-have for serious investors.

John D.

Financial Analyst

I have been using MarketXLS for the last 6+ years and they really enhanced the product every year and now in the journey of bringing in AI...

Kirubakaran K.

Investment Professional

MarketXLS is a powerful tool for financial modeling. It integrates seamlessly with Excel and provides real-time data.

David L.

Financial Analyst

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel.

Lloyd L.

Professional Trader